DOCSLIB.ORG

Charlotte Water 2019 Non-Detected Contaminants Contaminants

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Charlotte Water 2019 Non-Detected Contaminants Contaminants Charlotte Water 2019 Non-Detected Contaminants Contaminants Frequency Tested 1,1,1,2-Tetrachloroethane Quarterly 1,1,1-Trichloroethane Quarterly 1,1,2,2-Tetrachloroethane Quarterly 1,1,2-Trichloro-1,2,2-trifluoroethane Quarterly 1,1,2-Trichloroethane Quarterly 1,1-Dichloroethane Quarterly 1,1-Dichloroethylene Quarterly 1,1-Dichloropropanone Quarterly 1,1-Dichloropropene Quarterly 1,1-Dichloropropylene Quarterly 1,2,3-Trichlorobenzene Quarterly 1,2,3-Trichloropropane Quarterly 1,2,3-Trimethylbenzene Quarterly 1,2,4,5-Tetrachlorobenzene Quarterly 1,2,4-Trichlorobenzene Quarterly 1,2,4-Trimethylbenzene Quarterly 1,2-Dibromo-3-chloropropane (DBCP) 2Qtrs / 3Yrs 1,2-Dichlorobenzene Quarterly 1,2-Dichloroethane Quarterly 1,2-Dichloropropane Quarterly 1,2-Xylene Quarterly 1,3 + 1,4-Xylene Quarterly 1,3,5-Trimethylbenzene Quarterly 1,3,5-Trinitrobenzene Quarterly 1,3-Butadiene Quarterly 1,3-Dichlorobenzene Quarterly 1,3-Dichloropropane Quarterly 1,3-Dichloropropylene, cis & trans Quarterly 1,3-Dinitrobenzene Quarterly 1,4-Dichlorobenzene Quarterly 1,4-Dioxane Quarterly 1,7-Dimethylxanthine Quarterly 10:2 Fluorotelomer sulfonic acid (10:2 FTS) Quarterly 11-chloroeicosafluoro-3-oxaundecane-1-sulfonic acid (11Cl-PF3OUdS) Quarterly 11Cl-PF3OUdS/F-53B Minor Quarterly 17alpha-Ethynyl estradiol Quarterly 17beta-Estradiol Quarterly 1-Chlorobutane Quarterly 1-Methylnaphthalene Quarterly 1-Naphthol 2Qtrs / 3Yrs 2,2',3,3',4,4',6-Heptachlorobiphenyl Quarterly 2,2',3,3',4,5',6,6'-Octachlorobiphenyl Quarterly 2,2',3',4,6-Pentachlorobiphenyl Quarterly 2,2',4,4',5,5'-Hexabromobiphenyl (HBB) Quarterly 2,2',4,4',5,5'-Hexabromodiphenyl ether (BDE-153) Quarterly 2,2',4,4',5,6'-Hexachlorobiphenyl Quarterly 2,2',4,4',5-Pentabromodiphenyl ether (BDE-99) Quarterly 2,2',4,4',6-Pentabromodiphenyl ether (BDE-100) Quarterly 2,2',4,4'-Tetrabromodiphenyl ether (BDE-47) Quarterly 2,2',4,4'-Tetrachlorobiphenyl Quarterly 2,2-Dichloropropane Quarterly 2,3,7,8-Tetrachlorodibenzo-p-Dioxin, pg/L Quarterly 2,3-Dichlorobiphenyl Quarterly 2,4,5-T Quarterly 2,4,5-TP (Silvex) 2Qtrs / 3Yrs 2,4,5-Trichlorobiphenyl Quarterly 2,4,6-Trinitrotoluene Quarterly 2,4-D 2Qtrs / 3Yrs 2,4-DB Quarterly 2,4-Dinitrotoluene Quarterly 2,6-Dinitrotoluene Quarterly 2-Amino-4,6-dinitrotoluene Quarterly 2-Butanone (MEK) Quarterly 2-Chlorobiphenyl Quarterly 2-Chlorotoluene Quarterly 2-Hexanone Quarterly 2-Methylnaphthalene Quarterly 2-Nitropropane Quarterly 2-Nitrotoluene Quarterly 3,5-Dichlorobenzoic acid Quarterly 3-Hydroxycarbofuran 2Qtrs / 3Yrs 3-Nitrotoluene Quarterly 4,4'-DDD Quarterly 4,4'-DDE Quarterly 4,4'-DDT Quarterly 4,8-dioxa-3H-Perfluorononanoic acid (ADONA) Quarterly 4:2 Fluorotelomer sulfonic acid (4:2 FTS) Quarterly 4:2 Fluorotelomer sulfonic acid (4:2 FTS) Quarterly 4-Amino-2,6-dinitrotoluene Quarterly 4-Androstene-3,17-dione Quarterly 4-Chlorotoluene Quarterly 4-Isopropyltoluene Quarterly 4-Methyl-2-pentanone (MIBK) Quarterly 4-Nitrotoluene Quarterly 4-tert-Octylphenol Quarterly 6:2 Fluorotelomer sulfonic acid (6:2 FTS) Quarterly 8:2 Fluorotelomer sulfonic acid (8:2 FTS) Quarterly 9-chlorohexadecafluoro-3-oxanone-1-sulfonic acid (9Cl-PF3ONS) Quarterly 9Cl-PF3ONS/F-53B Major Quarterly Acenaphthene Quarterly Acenaphthylene Quarterly Acetaminophen Quarterly Acetochlor Quarterly Acetochlor ESA Quarterly Acetochlor OA Quarterly Acetone Quarterly Acifluorfen Quarterly Acrylamide Quarterly Acrylonitrile Quarterly ADONA Quarterly Alachlor 2Qtrs / 3Yrs Alachlor ESA Quarterly Alachlor OA Quarterly Albuterol Quarterly Aldicarb 2Qtrs / 3Yrs Aldicarb sulfone 2Qtrs / 3Yrs Aldicarb sulfoxide 2Qtrs / 3Yrs Aldrin 2Qtrs / 3Yrs Allyl chloride Quarterly Alpha-Chlordane Quarterly Alpha-Hexachlorocyclohexane Quarterly Ametryn Quarterly Amoxicillin Quarterly Anatoxin-a Quarterly Anilazine Quarterly Aniline Quarterly Anthracene Quarterly Antimony Quarterly Antipyrine Quarterly Arsenic Quarterly Aroclor 1016 2Qtrs / 3Yrs Aroclor 1221 2Qtrs / 3Yrs Aroclor 1232 2Qtrs / 3Yrs Aroclor 1242 2Qtrs / 3Yrs Aroclor 1248 2Qtrs / 3Yrs Aroclor 1254 2Qtrs / 3Yrs Aroclor 1260 2Qtrs / 3Yrs Asbestos Quarterly Aspon Quarterly Atenolol Quarterly Atraton Quarterly Atrazine 2Qtrs / 3Yrs Azinphos-ethyl Quarterly Azinphos-methyl Quarterly Azithromycin Quarterly Azoxystrobin Quarterly Barium Quarterly Baygon Quarterly Bendiocarb Quarterly Bendroflumethiazide Quarterly Benfluralin Quarterly Bensulide Quarterly Bentazon Quarterly Benzaldehyde Quarterly Benzene Quarterly Benzo(a)anthracene Quarterly Benzo(a)pyrene 2Qtrs / 3Yrs Benzo(b)fluoranthene Quarterly Benzo(g,h,i)perylene Quarterly Benzo(k)fluoranthene Quarterly Benzyl chloride Quarterly Beryllium Quarterly Bezafibrate Quarterly BHC - Gamma 2Qtrs / 3Yrs Bifenthrin Quarterly Bisphenol A Quarterly Bolstar Quarterly Bromacil Quarterly Bromobenzene Quarterly Bromochloromethane Quarterly Bromoform Quarterly Bromomethane Quarterly Butachlor Quarterly Butalbital Quarterly Butanal Quarterly Butylate Quarterly Butylbenzylphthalate Quarterly Butylparaben Quarterly Cadmium Quarterly Carbadox Quarterly Carbamazepine Quarterly Carbaryl Quarterly Carbofuran 2Qtrs / 3Yrs Carbon disulfide Quarterly Carbon tetrachloride Quarterly Carbophenothion Quarterly Carboxin Quarterly Carisoprodol Quarterly Chloramben Quarterly Chloramphenicol Quarterly Chlorfenvinphos Quarterly Chloridazon Quarterly Chloroacetonitrile Quarterly Chlorobenzene Quarterly Chlorobenzilate Quarterly Chlorodane 2Qtrs / 3Yrs Chlorodibromoacetic acid Quarterly Chloroethane Quarterly Chloromethane Quarterly Chloroneb Quarterly Chloropicrin Quarterly Chloroprene Quarterly Chloropropylate Quarterly Chlorothalonil Quarterly Chlorotoluron Quarterly Chlorpropham Quarterly Chlorpyrifos Quarterly Chlorpyrifos methyl Quarterly Chromium Quarterly Chrysene Quarterly Cimetidine Quarterly cis-1,2-Dichloroethylene Quarterly cis-1,3-Dichloropropylene Quarterly cis-Nonachlor Quarterly cis-Permethrin Quarterly Clofibric acid Quarterly Clomazone Quarterly Clopyralid Quarterly Cobalt Quarterly Cotinine Quarterly Coumaphos Quarterly Crotonaldehyde Quarterly Crotoxyphos Quarterly Cyanazine Quarterly Cyanide Quarterly Cycloate Quarterly Cyclohexanone Quarterly Cylindrospermopsin Quarterly Dalapon 2Qtrs / 3Yrs DCPA Quarterly DCPA acid metabolites Quarterly Decanal Quarterly Dehydronifedipine Quarterly delta-BHC Quarterly Demeton O Quarterly Demeton S Quarterly Desisopropylatrazine Quarterly Di(2-chloroethyl)ether Quarterly Di(2-ethylhexyl)adipate 2Qtrs / 3Yrs Di(2-ethylhexyl)phthalate 2Qtrs / 3Yrs Diazepam Quarterly Diazinon Quarterly Dibenzo(a,h)anthracene Quarterly Dibromoacetic acid Quarterly Dibromomethane Quarterly Dicamba 2Qtrs / 3Yrs Dichlobenil Quarterly Dichlofenthion Quarterly Dichloran Quarterly Dichlorobenzene Quarterly Dichlorodifluoromethane Quarterly Dichloromethane Quarterly Dichlorprop Quarterly Dichlorvos Quarterly Diclofenac Quarterly Dicrotophos Quarterly Dieldrin 2Qtrs / 3Yrs Diethylphthalate Quarterly Diflubenzuron Quarterly Diisopropyl ether Quarterly Dilantin Quarterly Diltiazem Quarterly Dimethoate Quarterly Dimethylphthalate Quarterly Di-n-butylphthalate Quarterly Di-n-octylphthalate Quarterly Dinoseb 2Qtrs / 3Yrs Dioxathion A Quarterly Dioxathion B Quarterly Diphenamid Quarterly Diquat Quarterly Disulfoton Quarterly Disulfoton sulfone Quarterly Disulfoton sulfoxide Quarterly Diuron Quarterly Endosulfan I Quarterly Endosulfan II Quarterly Endosulfan sulfate Quarterly Endrin 2Qtrs / 3Yrs Endrin aldehyde Quarterly E-Phosphamidon Quarterly Epichlorohydrin Quarterly EPN Quarterly EPTC Quarterly Erucylamide Quarterly Erythromycin Quarterly Esbiol Quarterly Esfenvalerate Quarterly Estriol Quarterly Estrone Quarterly Ethalfluralin Quarterly Ethion Quarterly Ethofumesate Quarterly Ethoprop Quarterly Ethyl acrylate Quarterly Ethyl Ether Quarterly Ethyl methacrylate Quarterly Ethyl tert-butyl ether Quarterly Ethylbenzene Quarterly Ethylene Dibromide (EDB) 2Qtrs / 3Yrs Ethylparaben Quarterly Etridiazole Quarterly F-53B Major Quarterly F-53B Minor Quarterly Famphur Quarterly Fenamiphos Quarterly Fenarimol Quarterly Fenitrothion Quarterly Fenoxaprop-ethyl Quarterly Fensulfothion Quarterly Fenthion Quarterly Fenuron Quarterly Fenvalerate Quarterly Fluazifop-butyl Quarterly Fluchloralin Quarterly Flumequine Quarterly Fluometuron Quarterly Fluoranthene Quarterly Fluorene Quarterly Fluorotrichloromethane Quarterly Fluoxetine (Prozac) Quarterly Fluridone Quarterly Fonofos Quarterly Formaldehyde Quarterly Gamma-BHC (Lindane) 2Qtrs / 3Yrs Gamma-Chlordane Quarterly Gemfibrozil Quarterly GenX Quarterly Germanium Quarterly Glyoxal Quarterly Gross Alpha - Excl. Radon & Uranium Quarterly Gross Alpha - Incl. Radon & Uranium Quarterly Gross Beta Particle Activity Quarterly Halofenozide Quarterly Halosulfuron methyl Quarterly Heptachlor 2Qtrs / 3Yrs Heptachlor epoxide 2Qtrs / 3Yrs Heptanal Quarterly Hexachlorobenzene 2Qtrs / 3Yrs Hexachlorobutadiene Quarterly Hexachlorocyclopentadiene 2Qtrs / 3Yrs Hexachloroethane Quarterly Hexafluoropropylene oxide dimer acid (HFPO-DA) Quarterly Hexanal Quarterly Hexazinone Quarterly HFPO-DA/GenX Quarterly HMX (Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine) Quarterly Ibuprofen Quarterly Imidacloprid Quarterly Indeno(1,2,3-cd)pyrene Quarterly Iodide Quarterly Iopromide Quarterly Iprodione Quarterly Isobutylparaben Quarterly Isofenphos Quarterly Isophorone Quarterly Isopropylbenzene Quarterly Isoproturon Quarterly Kepone Quarterly Ketoprofen Quarterly Ketorolac Quarterly Lasso 2Qtrs / 3Yrs Lead Quarterly Leptophos Quarterly Lidocaine Quarterly Lindane Quarterly Linuron Quarterly Lithium Quarterly Lopressor
Load more

Recommended publications
  • Guidelines for the Forensic Analysis of Drugs Facilitating Sexual Assault and Other Criminal Acts
    Vienna International Centre, PO Box 500, 1400 Vienna, Austria Tel.: (+43-1) 26060-0, Fax: (+43-1) 26060-5866, www.unodc.org Guidelines for the Forensic analysis of drugs facilitating sexual assault and other criminal acts United Nations publication Printed in Austria ST/NAR/45 *1186331*V.11-86331—December 2011 —300 Photo credits: UNODC Photo Library, iStock.com/Abel Mitja Varela Laboratory and Scientific Section UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Guidelines for the forensic analysis of drugs facilitating sexual assault and other criminal acts UNITED NATIONS New York, 2011 ST/NAR/45 © United Nations, December 2011. All rights reserved. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. List of abbreviations . v Acknowledgements .......................................... vii 1. Introduction............................................. 1 1.1. Background ........................................ 1 1.2. Purpose and scope of the manual ...................... 2 2. Investigative and analytical challenges ....................... 5 3 Evidence collection ...................................... 9 3.1. Evidence collection kits .............................. 9 3.2. Sample transfer and storage........................... 10 3.3. Biological samples and sampling ...................... 11 3.4. Other samples ...................................... 12 4. Analytical considerations .................................. 13 4.1. Substances encountered in DFSA and other DFC cases .... 13 4.2. Procedures and analytical strategy...................... 14 4.3. Analytical methodology .............................. 15 4.4.
    [Show full text]
  • 3745-100-10 Applicable Chemicals and Chemical Categories
    3745-100-10 Applicable chemicals and chemical categories. [Comment: For dates of non-regulatory government publications, publications of recognized organizations and associations, federal rules, and federal statutory provisions referenced in this rule, see the "Incorporation by Reference" section at the end of rule 3745-100-01.] The requirements of this chapter apply to the following chemicals and chemical categories. This rule contains three listings. Paragraph (A) of this rule is an alphabetical order listing of those chemicals that have an associated "Chemical Abstracts Service (CAS)" registry number. Paragraph (B) of this rule contains a CAS registry number order list of the same chemicals listed in paragraph (A) of this rule. Paragraph (C) of this rule contains the chemical categories for which reporting is required. These chemical categories are listed in alphabetical order and do not have CAS registry numbers. (A) Alphabetical listing: -- Chemical Name CAS Number abamectin (avermectin B1) 71751-41-2 acephate (acetylphosphoramidothioic acid o,s-dimethyl ester) 30560-19-1 acetaldehyde 75-07-0 acetamide 60-35-5 acetonitrile 75-05-8 acetophenone 98-86-2 2-acetylaminofluorene 53-96-3 acifluorfen, sodium salt (5- (2-chloro-4- (trifluoromethyl) - phenoxy)-2-nitro-benzoic acid, sodium salt) 62476-59-9 acrolein 107-02-8 acrylamide 79-06-1 acrylic acid 79-10-7 acrylonitrile 107-13-1 alachlor 15972-60-8 aldicarb 116-06-3 aldrin [1,4,5,8-dimethanonaphthalene, 1,2,3,4,10,10-hexachloro- 1,4,4A,5,8,8a-hexahydro- (1 alpha, 4 alpha, 4a beta, 5
    [Show full text]
  • ACTION: Original DATE: 08/20/2020 9:51 AM
    ACTION: Original DATE: 08/20/2020 9:51 AM TO BE RESCINDED 3745-100-10 Applicable chemicals and chemical categories. [Comment: For dates of non-regulatory government publications, publications of recognized organizations and associations, federal rules, and federal statutory provisions referenced in this rule, see paragraph (FF) of rule 3745-100-01 of the Administrative Code titled "Referenced materials."] The requirements of this chapter apply to the following chemicals and chemical categories. This rule contains three listings. Paragraph (A) of this rule is an alphabetical order listing of those chemicals that have an associated "Chemical Abstracts Service (CAS)" registry number. Paragraph (B) of this rule contains a CAS registry number order list of the same chemicals listed in paragraph (A) of this rule. Paragraph (C) of this rule contains the chemical categories for which reporting is required. These chemical categories are listed in alphabetical order and do not have CAS registry numbers. (A) Alphabetical listing: Chemical Name CAS Number abamectin (avermectin B1) 71751-41-2 acephate (acetylphosphoramidothioic acid o,s-dimethyl ester) 30560-19-1 acetaldehyde 75-07-0 acetamide 60-35-5 acetonitrile 75-05-8 acetophenone 98-86-2 2-acetylaminofluorene 53-96-3 acifluorfen, sodium salt [5-(2-chloro-4-(trifluoromethyl)phenoxy)-2- 62476-59-9 nitrobenzoic acid, sodium salt] acrolein 107-02-8 acrylamide 79-06-1 acrylic acid 79-10-7 acrylonitrile 107-13-1 [ stylesheet: rule.xsl 2.14, authoring tool: RAS XMetaL R2_0F1, (dv: 0, p: 185720, pa:
    [Show full text]
  • Forensic Toxicology Laboratory Office of Chief Medical Examiner City of New York
    FORENSIC TOXICOLOGY LABORATORY OFFICE OF CHIEF MEDICAL EXAMINER CITY OF NEW YORK CARISOPRODOL , MEPROBAMATE and TOPIRAMATE by SOLID PHASE EXTRACTION and GAS CHROMATOGRAPHY/MASS SPECTROMETRY (Selected Ion Monitoring) PRINCIPLE Carisoprodol is a carbamate derivative first synthesized in 1959. It is primarily used as a muscle relaxant. UncontrolledMeprobamate is also a carbamate derivative used as a muscle relaxant and the primary metabolite of carisoprodol. Topiramate is a sulfamate-substituted monosaccharide used as an anticonvulsant Carisoprodol, meprobamate and topiramate are quantitated by a selected ion monitoring (SIM) method using methapyrilene as the internal standard. Carisoprodol, meprobamate and topiramate are extracted from biological specimens by solid phase extraction. Drugs are temporarily bound to a sorbent in the solid phase cartridge as the prepared sample is poured through the column. The column is washed to remove interfering compounds, followed by elution of drugs from the column. The eluate is evaporated, reconstituted and injected in the GCMS. Quantitative analysis is performed by SIM GCMS using a six point calibration curve. SAFETY The handling of all biological specimens and reagents is performed within the guidelines which are detailed in the Safety and Health manual. Copy SPECIMEN PREPARATION The procedure is routinely applied to the following biological specimens and their aliquots unless otherwise specified: Blood 0.5 mL of the undiluted specimen Urine 0.5 mL for qualitative identification Brain 0.5 mL of a 1:3 homogenate Gastric Contents 0.5 mL of a 1:10 dilution Liver 0.5 mL of a 1:5 homogenate Vitreous Humor 0.5 mL of the undiluted specimen Bile 0.5 mL of the undiluted specimen Reviewed by: Date: Page 1 of 14 T:\FINALSOP\FINAL SOP PDF\G.
    [Show full text]
  • Assessment of Molecular Action of Direct Gating and Allosteric Modulatory Effects of Carisoprodol (Somartm) on GABA a Receptors
    Graduate Theses, Dissertations, and Problem Reports 2015 Assessment of molecular action of direct gating and allosteric modulatory effects of carisoprodol (SomaRTM) on GABA A receptors Manoj Kumar Follow this and additional works at: https://researchrepository.wvu.edu/etd Recommended Citation Kumar, Manoj, "Assessment of molecular action of direct gating and allosteric modulatory effects of carisoprodol (SomaRTM) on GABA A receptors" (2015). Graduate Theses, Dissertations, and Problem Reports. 6022. https://researchrepository.wvu.edu/etd/6022 This Dissertation is protected by copyright and/or related rights. It has been brought to you by the The Research Repository @ WVU with permission from the rights-holder(s). You are free to use this Dissertation in any way that is permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/ or on the work itself. This Dissertation has been accepted for inclusion in WVU Graduate Theses, Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU. For more information, please contact [email protected]. ASSESSMENT OF MOLECULAR ACTION OF DIRECT GATING AND ALLOSTERIC MODULATORY EFFECTS OF MEPROBAMATE (MILTOWN®) ON GABAA RECEPTORS Manish Kumar, MD, MS Dissertation submitted to the School of Pharmacy at West Virginia University in partial fulfillment of Requirements
    [Show full text]
  • Urine Drug Toxicology and Pain Management Testing
    Urine Drug Toxicology and Pain Management Testing Kara Lynch, PhD, DABCC University of California San Francisco San Francisco, CA Learning Objectives • Describe what chronic pain is, who is affected and how they are commonly treated • Explain the common methodologies used in pain management testing • Interpret urine drug testing results • Create protocols to minimize the occurrence of false positive or false negative results Pain – definition and types • Pain - an unpleasant sensory and emotional experience associated with actual or potential tissue damage • Chronic pain - pain that extends beyond the expected period of healing • Nociceptive Pain – Pain caused by tissue injury – Stimulus-evoked, high intensity – Opioid sensitive • Neuropathic Pain – Caused by nerve injury – Spontaneous activity – Develops in days or month – Opioid insensitive Chronic Pain Patients • Arthritis • Fibromyalgia – Osteoarthritis • Headaches – Rheumatoid arthritis – Migraine – Gout – Tension • Cancer – Cluster • Chronic non-cancer pain • Myofascial pain • Central pain syndrome • Neuropathic pain – CNS damage – Diabetic Peripheral – Multiple Sclerosis Neuropathy – Parkinson’s disease – Postherpetic neuralgia • Chronic abnominal pain • Neck and Back Pain – Intestinal obstructions Chronic Pain Medications • Opiates • Synthetic opioids – Codeine – Fentanyl – Morphine – Methadone • Semi-synthetic opioids – Meperidine – Oxymorphone – Tramadol – Oxycodone – Propoxyphene – Hydromorphone – Levorphanol – Hydrocodone – Tapentadol – Buprenorphine • Anticonvulsant • Muscle
    [Show full text]
  • 2021 Formulary List of Covered Prescription Drugs
    2021 Formulary List of covered prescription drugs This drug list applies to all Individual HMO products and the following Small Group HMO products: Sharp Platinum 90 Performance HMO, Sharp Platinum 90 Performance HMO AI-AN, Sharp Platinum 90 Premier HMO, Sharp Platinum 90 Premier HMO AI-AN, Sharp Gold 80 Performance HMO, Sharp Gold 80 Performance HMO AI-AN, Sharp Gold 80 Premier HMO, Sharp Gold 80 Premier HMO AI-AN, Sharp Silver 70 Performance HMO, Sharp Silver 70 Performance HMO AI-AN, Sharp Silver 70 Premier HMO, Sharp Silver 70 Premier HMO AI-AN, Sharp Silver 73 Performance HMO, Sharp Silver 73 Premier HMO, Sharp Silver 87 Performance HMO, Sharp Silver 87 Premier HMO, Sharp Silver 94 Performance HMO, Sharp Silver 94 Premier HMO, Sharp Bronze 60 Performance HMO, Sharp Bronze 60 Performance HMO AI-AN, Sharp Bronze 60 Premier HDHP HMO, Sharp Bronze 60 Premier HDHP HMO AI-AN, Sharp Minimum Coverage Performance HMO, Sharp $0 Cost Share Performance HMO AI-AN, Sharp $0 Cost Share Premier HMO AI-AN, Sharp Silver 70 Off Exchange Performance HMO, Sharp Silver 70 Off Exchange Premier HMO, Sharp Performance Platinum 90 HMO 0/15 + Child Dental, Sharp Premier Platinum 90 HMO 0/20 + Child Dental, Sharp Performance Gold 80 HMO 350 /25 + Child Dental, Sharp Premier Gold 80 HMO 250/35 + Child Dental, Sharp Performance Silver 70 HMO 2250/50 + Child Dental, Sharp Premier Silver 70 HMO 2250/55 + Child Dental, Sharp Premier Silver 70 HDHP HMO 2500/20% + Child Dental, Sharp Performance Bronze 60 HMO 6300/65 + Child Dental, Sharp Premier Bronze 60 HDHP HMO
    [Show full text]
  • Sedation in Fmri : an Unsolved Challenge
    Sedation in fMRI : An unsolved challenge Byron Bernal *, MD Nolan Altman**, MD There are many medications that can be utilized to sedate children undergoing fMR examinations. The most frequently used drugs are chloral hydrate, thiopenthal, phenobarbital, propofol, and fentanyl. These medications have some secondary effects on the electrical and metabolic activity of the cortex, cerebral blood flow(CBF), cerebral blood volume(CBV), and tissue oxygen extraction. These effects are of no concern in regular MRI (Magnetic Resonance Imaging), however, may have a significant contribution in fMR performed in the sedated child. Since fMRI is based on the hemodynamic and metabolic response of the brain to a given stimulus the selection of the sedation medication seems crucial. The following reviews the current knowledge regarding the relation of these drugs to these physiological parameters. Chloral Hydrate.- Chloral hydrate (CH) does not reduce brain cortex activity. This is demonstrated on EEG where it is widely used. Thoresen M and Henriksen O (1997) did not find changes on the EEGs in 9 out of 13 children with epileptic seizures, before and after CH was administered. We do not know of any reported studies relating CBF, CBV, or cerebral regional metabolism changes, and CH in humans. Propofol.- Propofol has been used as a sedative in children undergoing EEGs. Low propofol doses (0.5- 1 mg/kg) show an increase in the number of beta-waves and a significant reduction of alpha- and theta- waves . Larger doses of propofol (total dose of 2-2.5 mg/kg), the number of beta-waves decreased and delta-waves appeared.
    [Show full text]
  • 2013 National Survey on Drug Use and Health
    140324 Table 1.88C Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Standard Errors of Numbers in Thousands, 2012 and 2013 Total Total Aged 12-17 Aged 12-17 Aged 18-25 Aged 18-25 Aged 26+ Aged 26+ Drug or Method of Administration (2012) (2013) (2012) (2013) (2012) (2013) (2012) (2013) HALLUCINOGENS 674 707 39 35 131 133 641 678 PCP (Angel Dust, Phencyclidine) 311 346 13 8 30 30 309 342 LSD (Acid) 561 580 21 19 87 81 538 567 Peyote 338 328 10 9 31 33 331 327 Mescaline 362 378 7 6 30 35 359 375 Psilocybin (Mushrooms) 524 561 24 22 99 100 502 542 Ecstasy (MDMA) 405 464 30 24 117 114 374 442 INHALANTS 489 519 51 52 84 85 471 505 Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 311 364 21 18 40 40 306 357 Correction Fluid, Degreaser, or Cleaning Fluid 162 100 26 26 28 26 157 91 Gasoline or Lighter Fluid 184 164 31 28 40 29 174 156 Glue, Shoe Polish, or Toluene 182 175 31 31 32 30 175 168 Halothane, Ether, or Other Anesthetics 89 85 8 10 15 17 88 84 Lacquer Thinner or Other Paint Solvents 132 117 21 18 21 21 130 114 Lighter Gases (Butane, Propane) 91 80 18 15 16 17 89 77 Nitrous Oxide or Whippits 365 409 18 17 71 70 349 399 Spray Paints 123 121 34 24 28 28 115 115 Other Aerosol Sprays 154 130 24 21 33 39 149 121 NEEDLE USE1,2,3 225 265 10 10 38 40 222 261 Heroin Needle Use1,2 162 211 7 6 28 33 161 209 Cocaine Needle Use1,2 160 193 3 1 20 21 158 192 Stimulant Needle Use1,2,3 143 199 4 5 22 26 139 196 Methamphetamine Needle Use1,2,3 134 185 3 5 21 22 131 182 HEROIN 245 281 12 9 43 44 241 278 Smoke Heroin2 153 152 9 5 30 32 148 150 Sniff or Snort Heroin2 203 215 5 5 35 35 203 212 *Low precision; no estimate reported.
    [Show full text]
  • List of Lists
    United States Office of Solid Waste EPA 550-B-10-001 Environmental Protection and Emergency Response May 2010 Agency www.epa.gov/emergencies LIST OF LISTS Consolidated List of Chemicals Subject to the Emergency Planning and Community Right- To-Know Act (EPCRA), Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) and Section 112(r) of the Clean Air Act • EPCRA Section 302 Extremely Hazardous Substances • CERCLA Hazardous Substances • EPCRA Section 313 Toxic Chemicals • CAA 112(r) Regulated Chemicals For Accidental Release Prevention Office of Emergency Management This page intentionally left blank. TABLE OF CONTENTS Page Introduction................................................................................................................................................ i List of Lists – Conslidated List of Chemicals (by CAS #) Subject to the Emergency Planning and Community Right-to-Know Act (EPCRA), Comprehensive Environmental Response, Compensation and Liability Act (CERCLA) and Section 112(r) of the Clean Air Act ................................................. 1 Appendix A: Alphabetical Listing of Consolidated List ..................................................................... A-1 Appendix B: Radionuclides Listed Under CERCLA .......................................................................... B-1 Appendix C: RCRA Waste Streams and Unlisted Hazardous Wastes................................................ C-1 This page intentionally left blank. LIST OF LISTS Consolidated List of Chemicals
    [Show full text]
  • The ARS Pesticide Properties Database
    Crop Systems & Global Change Products and Services Page 1 of 1 Beltsville Beltsville Agricultural Rsch. Ctr. Crop Systems & Global Change Printable Version E-mail this page You are here: Products & Services / Database Files / Pesticide Properties Database Enter Keywords This site only Advanced Search Pesticide Properties DataBase ARS Products & Services Links ARS Products & Services PPDB TEKTRAN The ARS Pesticide Properties Database Introduction Description Publications Coden List Full Text Publications Units (.pdf) Pesticide list Public Databases and Combined File Programs (lists all pesticides. Takes ARS Cotton Database several minutes BARC Weather Stations to display) Pesticide Properties Database Technical Contact: Dennis Timlin. CSGCL, 301-504- 6255 [email protected] Last Modified: 11/06/2009 ARS Home | USDA.gov | Site Map | Policies and Links FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House http://www.ars.usda.gov/services/docs.htm?docid=14199 2/27/2013 Crop Systems & Global Change Products and Services Page 1 of 19 Beltsville Beltsville Agricultural Rsch. Ctr. Crop Systems & Global Change Printable Version E-mail this page You are here: Products & Services / Enter Keywords This site only Advanced Search Coden List ARS Products & Services Links ARS Products & Services 1800AJ TEKTRAN V.H.FREED, "CHEMISTRY OF HERBICIDES & PESTICIDES AND THEIR EFFECTS ON SOIL & WATER", SOIL SCIENCE Publications SOCIETY OF Full Text Publications (.pdf) Public Databases and Programs 5OLSEN OLSEN, L.D., ROMAN-MAS, A., WEISSKOPF, C.P., AND KLAINE, S.J. "TRANSPORT AND DEGRADATION OF ALDICARB IN THE SOIL PROFILE:---", PROC. 1994 AWRA NAT. SYMP. WATER QUALITY, 1994, 6ABERN ABERNATHY, J.R. "LINURON, CHLORBROMURON, NITROFEN & FLUBRODIFEN ADSORPTION AND MOVEMENT IN TWELVE SELECTED OF 6ACSAR AMERICAN CHEMICAL SOCIETY, WASH., D.C., "ARSENICAL PESTICIDE".
    [Show full text]
  • 1,1,1 -Trichloroethane (M E T H Y L C H L O R O F O R M)
    criteria for a recommended standard occupational exposure to 1,1,1 -trichloroethane (m e t h y l c h l o r o f o r m) U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service Center for Disease Control National Institute for Occupational Safety and Health criteria for a recommended standard.. OCCUPATIONAL EXPOSURE TO 1,1,1 - TRICHLOROETHANE (Methyl Chloroform) U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service Center for Disease Control National Institute for Occupational Safety and Health JULY 1976 HEW Publication No. (NIOSH) 76-184 PREFACE The Occupational Safety and Health Act of 1970 emphasizes the need for standards to protect the health and safety of workers exposed to an ever-increasing number of potential hazards at their workplace. The National Institute for Occupational Safety and Health has projected a formal system of research, with priorities determined on the basis of specified indices, to provide relevant data from which valid criteria for effective standards can be derived. Recommended standards for occupational exposure, which are the result of this work, are based on the health effects of exposure. The Secretary of Labor will weigh these recommen­ dations along with other considerations such as feasibility and means of implementation in developing regulatory standards. It is intended to present successive reports as research and epide­ miologic studies are completed and as sampling and analytical methods are developed. Criteria and standards will be reviewed periodically to ensure continuing protection of the worker. I am pleased to acknowledge the contributions to this report on 1,1,1-trichloroethane by members of my staff and the valuable, constructive comments by the Review Consultants on 1,1,1-Trichloroethane, by the ad hoc committees of the American Industrial Hygiene Association and the American Academy of Occupational Medicine, and by Robert B.
    [Show full text]